10 Cathie Wood Prime Medicine Trades
Cathie Wood's position in Prime Medicine is currently worth $4.02 Million. That's 0.04% of their equity portfolio (105th largest holding). Cathie Wood started to build up the position in Prime Medicine in Q4 2022 and continued to invest until Q2 2024. Since then they sold 3.03 Million shares. The investor's estimated purchase price is $35.5 Million, resulting in a loss of 89%.
Avg closing price
Price range
Sold 39.9% shares (-2.06 Million shares)
Q1 2025
Avg closing price
$2.57
Price range
$1.72
-
$3.35
Sold 9.0% shares (-510 Thousand shares)
Q4 2024
Avg closing price
$3.50
Price range
$2.76
-
$4.46
Sold 7.6% shares (-466 Thousand shares)
Q3 2024
Avg closing price
$4.64
Price range
$3.41
-
$6.70
Increased shares by 2.2% (+133 Thousand shares)
Q2 2024
Avg closing price
$6.06
Price range
$4.30
-
$8.03
Increased shares by 91.0% (+2.86 Million shares)
Q1 2024
Avg closing price
$7.58
Price range
$6.35
-
$9.39
Increased shares by 19.7% (+516 Thousand shares)
Q4 2023
Avg closing price
$7.70
Price range
$5.59
-
$9.55
Increased shares by 7.1% (+173 Thousand shares)
Q3 2023
Avg closing price
$12.99
Price range
$9.50
-
$15.07
Increased shares by 27.4% (+527 Thousand shares)
Q2 2023
Avg closing price
$13.96
Price range
$11.41
-
$17.05
Increased shares by 17.2% (+282 Thousand shares)
Q1 2023
Avg closing price
$16.29
Price range
$11.21
-
$21.11
New holding (+1.64 Million shares)
Q4 2022
Avg closing price
$18.06
Price range
$15.20
-
$21.12
